直肠癌临床实践指南（NCCN 肿瘤学版）2018 年第 2 版
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
出版信息
J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in patients with rectal cancer. This portion of the guidelines focuses on the management of localized disease, which involves careful patient selection for curative-intent treatment options that sequence multimodality therapy usually comprised of chemotherapy, radiation, and surgical resection.
摘要
美国国家综合癌症网络（NCCN）肿瘤学临床实践指南（NCCN 指南）针对直肠癌的诊断、分期、手术治疗、围手术期治疗、复发性和转移性疾病的治疗、疾病监测以及直肠癌患者的生存问题提供了指导建议。本指南的这一部分重点关注局限性疾病的治疗管理，这需要对适合接受根治性治疗方案的患者进行仔细选择，这些方案通常包括化疗、放疗和手术切除的多模式治疗。
相似文献
1
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.
2
Management of Locoregional Rectal Cancer.
J Natl Compr Canc Netw. 2018 May;16(5S):617-619. doi: 10.6004/jnccn.2018.0037.
3
Evolving Treatment Paradigm in the Treatment of Locally Advanced Rectal Cancer.
J Natl Compr Canc Netw. 2018 Jul;16(7):909-915. doi: 10.6004/jnccn.2018.7032.
4
Rectal Cancer in 2018: A Primer for the Gastroenterologist.
Am J Gastroenterol. 2018 Dec;113(12):1763-1771. doi: 10.1038/s41395-018-0180-y.
5
Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.
6
Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
BMC Cancer. 2018 May 8;18(1):538. doi: 10.1186/s12885-018-4466-7.
7
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv19-iv29. doi: 10.1093/annonc/mdy080.
8
Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus.
J Gastrointest Cancer. 2020 Sep;51(3):800-804. doi: 10.1007/s12029-020-00454-4.
9
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
J Natl Compr Canc Netw. 2024 Aug;22(6):366-375. doi: 10.6004/jnccn.2024.0041.
10
[Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jun 25;22(6):527-533. doi: 10.3760/cma.j.issn.1671-0274.2019.06.005.
引用本文的文献
1
Is neoadjuvant immunotherapy feasible for patients with dMMR/MSI-H locally advanced colorectal cancer? a retrospective study.
Front Immunol. 2025 Aug 12;16:1645412. doi: 10.3389/fimmu.2025.1645412. eCollection 2025.
2
Lymph node morphology as an MRI biomarker for microsatellite instability in rectal cancer.
Abdom Radiol (NY). 2025 Aug 14. doi: 10.1007/s00261-025-05161-x.
3
Controversies and Perspectives in the Current Management of Patients with Locally Advanced Rectal Cancer-A Systematic Review.
Life (Basel). 2025 Jun 25;15(7):1011. doi: 10.3390/life15071011.
4
Baseline MRI habitat imaging for predicting treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Front Oncol. 2025 Jul 11;15:1551224. doi: 10.3389/fonc.2025.1551224. eCollection 2025.
5
Log odds of positive lymph nodes-based staging system for colorectal cancer patients with inadequate lymph nodes harvested: a potential reference for adjuvant chemotherapy.
J Gastrointest Oncol. 2025 Jun 30;16(3):1038-1049. doi: 10.21037/jgo-2024-910. Epub 2025 Jun 16.
6
Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study.
NPJ Precis Oncol. 2025 Jul 12;9(1):237. doi: 10.1038/s41698-025-01018-0.
7
Narrative Review: Predictive Biomarkers of Tumor Response to Neoadjuvant Radiotherapy or Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer Patients.
Cancers (Basel). 2025 Jul 3;17(13):2229. doi: 10.3390/cancers17132229.
8
A comparative study of machine learning models for predicting neoadjuvant chemoradiotheraphy response in rectal cancer patients using radiomics and clinical features.
Medicine (Baltimore). 2025 Jul 4;104(27):e43173. doi: 10.1097/MD.0000000000043173.
9
Tuning vision foundation models for rectal cancer segmentation from CT scans.
Commun Med (Lond). 2025 Jul 1;5(1):256. doi: 10.1038/s43856-025-00953-0.
10
A new way to remedy anastomotic leakage after TaTME: A case report.
Int J Surg Case Rep. 2025 Jul;132:111047. doi: 10.1016/j.ijscr.2025.111047. Epub 2025 Mar 18.
本文引用的文献
1
Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
Ann Surg. 2019 Jun;269(6):1117-1123. doi: 10.1097/SLA.0000000000002719.
2
Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection.
JAMA Oncol. 2018 Jul 1;4(7):938-943. doi: 10.1001/jamaoncol.2018.0231.
3
Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Oncologist. 2019 Jun;24(6):803-811. doi: 10.1634/theoncologist.2017-0600. Epub 2018 Apr 19.
4
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03).
Oncologist. 2018 Aug;23(8):912-918. doi: 10.1634/theoncologist.2017-0484. Epub 2018 Mar 9.
5
Cancer statistics, 2018.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer.
J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx095.
7
Restaging Abdominopelvic Computed Tomography Before Surgery After Preoperative Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
JAMA Oncol. 2018 Feb 1;4(2):259-262. doi: 10.1001/jamaoncol.2017.4596.
8
Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial.
JAMA. 2017 Oct 24;318(16):1569-1580. doi: 10.1001/jama.2017.7219.
9
Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.
Eur Radiol. 2018 Apr;28(4):1465-1475. doi: 10.1007/s00330-017-5026-2. Epub 2017 Oct 17.
10
Outcomes of robotic versus laparoscopic surgery for mid and low rectal cancer after neoadjuvant chemoradiation therapy and the effect of learning curve.
Medicine (Baltimore). 2017 Oct;96(40):e8171. doi: 10.1097/MD.0000000000008171.
Zotero 插件